Newly developed TGF-β2 knock down transgenic mouse lines express TGF-β2 differently and its distribution in multiple tissues varies

BMC Biochemistry

Volumn 14, Issue 1, 2013, Pages

  Xiyang, Yan Bin ^a   Wang, Fang ^a   Qian, Bao Jiang ^a   You, Ling ^a   Lu, Bing Tuan ^a   Zhang, Wei ^c   Quan, Xiong Zhi ^c   Ge, Wen Ping ^c   Liu, Su ^a   Zhang, Lian Feng ^c,d   Wang, Ting Hua ^a,b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Distributions; Knock down; Protein levels; TGF 2; Transgenic mouse

Indexed keywords

SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE SILENCING; GENETIC MANIPULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE LEVEL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; GENE EXPRESSION REGULATION; GENOTYPE; HOMOZYGOTE; MICE; MICE, TRANSGENIC; PHENOTYPE; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA2;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84881059238     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-14-21     Document Type: Article

References (28)

1. The glial scar and central nervous system repair. Fawcett JW, Asher RA, Brain Res Bull 1999 49 377 391 10.1016/S0361-9230(99)00072-6 10483914 (Pubitemid 29385505)
2. Spinal cord injuries. Beynon A, Nurs Stand 2011 25 59 21928592
3. Neurotrophic factors in combinatorial approaches for spinal cord regeneration. McCall J, Weidner N, Blesch A, Cell Tissue Res 2012 349 27 37 10.1007/s00441-012-1388-6 22526621
4. Adenovirus vector-mediated in vivo gene transfer of brain-derived neurotrophic factor (BDNF) promotes rubrospinal axonal regeneration and functional recovery after complete transection of the adult rat spinal cord. Koda M, Hashimoto M, Murakami M, Yoshinaga K, Ikeda O, Yamazaki M, J Neurotrauma 2004 21 329 337 10.1089/089771504322972112 15115607 (Pubitemid 38401754)
5. Adenovirus-mediated delivery of GDNF ameliorates corticospinal neuronal atrophy and motor function deficits in rats with spinal cord injury. Tang XQ, Wang Y, Huang ZH, Han JS, Wan Y, Neuroreport 2004 15 425 429 10.1097/00001756-200403010-00009 15094497 (Pubitemid 38328134)
6. Adeno-associated viral vector- mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Ruitenberg MJ, Blits B, Dijkhuizen PA, te Beek ET, Bakker A, van Heerikhuize JJ, Pool CW, Hermens WT, Boer GJ, Verhaagen J, Neurobiol Dis 2004 15 394 406 10.1016/j.nbd.2003.11.018 15006710 (Pubitemid 38304891)
7. Insect prothoracicotropic hormone: a new member of the vertebrate growth factor superfamily. Noguti T, Adachi-Yamada T, Katagiri T, Kawakami A, Iwami M, Ishibashi J, Kataoka H, Suzuki A, Go M, Ishizaki H, FEBS Lett 1995 376 251 256 10.1016/0014-5793(95)01296-8 7498553
8. Neurons promote macrophage proliferation by producing transforming growth factor-beta2. Dobbertin A, Schmid P, Gelman M, Glowinski J, Mallat M, J Neurosci 1997 17 5305 5315 9204915 (Pubitemid 27300298)
9. TGF-beta signal transduction. Massague J, Annu Rev Biochem 1998 67 753 791 10.1146/annurev.biochem.67.1.753 9759503 (Pubitemid 28411144)
10. TGFbeta signaling in growth control, cancer, and heritable disorders. Massague J, Blain SW, Lo RS, Cell 2000 103 295 309 10.1016/S0092-8674(00)00121-5 11057902
11. Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy. Anjaneyulu M, Berent-Spillson A, Inoue T, Choi J, Cherian K, Russell JW, Exp Neurol 2008 211 469 479 10.1016/j.expneurol.2008.02.011 18406405
12. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Saika S, Cornea 2004 23 25 S30 10.1097/01.ico.0000136668.41000.73 15448476
13. A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. Zhang L, Wang W, Hayashi Y, Jester JV, Birk DE, Gao M, Liu CY, Kao WW, Karin M, Xia Y, EMBO J 2003 22 4443 4454 10.1093/emboj/cdg440 12941696 (Pubitemid 37087198)
14. Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Krieglstein K, Richter S, Farkas L, Schuster N, Dünker N, Oppenheim RW, Unsicker K, Nat Neurosci 2000 3 1085 1090 10.1038/80598 11036264
15. Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Carrington LM, Albon J, Anderson I, Kamma C, Boulton M, Invest Ophthalmol Vis Sci 2006 47 1886 1894 10.1167/iovs.05-0635 16638995 (Pubitemid 46768268)
16. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, Brook GA, Spinal Cord 2008 46 364 371 10.1038/sj.sc.3102148 18040277 (Pubitemid 351630959)
17. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T, Development 1997 124 2659 2670 9217007 (Pubitemid 27341765)
18. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ, Cancer Res 2007 67 11517 11527 10.1158/0008-5472.CAN-07-1284 18089780
19. Transforming growth factor-betas in neurodegenerative disease. Flanders KC, Ren RF, Lippa CF, Prog Neurobiol 1998 54 71 85 10.1016/S0301-0082(97)00066-X 9460794 (Pubitemid 28049820)
20. Transforming growth factor-beta: neuronal and glial expression in CNS degenerative diseases. Lippa CF, Smith TW, Flanders KC, Neurodegeneration 1995 4 425 432 10.1006/neur.1995.0051 8846236 (Pubitemid 26016588)
21. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. De Groot CJ, Montagne L, Barten AD, Sminia P, Van Der Valk P, J Neuropathol Exp Neurol 1999 58 174 187 10.1097/00005072- 199902000-00007 10029100 (Pubitemid 29088941)
22. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Lagord C, Berry M, Logan A, Mol Cell Neurosci 2002 20 69 92 10.1006/mcne.2002.1121 12056841 (Pubitemid 34634329)
23. Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. Peress NS, Perillo E, J Neuropathol Exp Neurol 1995 54 802 811 10.1097/00005072-199511000-00007 7595653
24. Real-time monitoring of the interactions of transforming growth factor- beta (TGF-beta) isoforms with latency-associated protein and the ectodomains of the TGF-beta type II and III receptors reveals different kinetic models and stoichiometries of binding. De Crescenzo G, Grothe S, Zwaagstra J, Tsang M, O'Connor-McCourt MD, J Biol Chem 2001 276 29632 29643 10.1074/jbc.M009765200 11382746
25. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Goumans MJ, Mummery C, Int J Dev Biol 2000 44 253 265 10853822 (Pubitemid 30368069)
26. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, Ledbetter S, Mustoe TA, J Am Coll Surg 2005 201 391 397 10.1016/j.jamcollsurg.2005.03.032 16125072 (Pubitemid 41206777)
27. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Nature 1992 359 693 699 10.1038/359693a0 1436033
28. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S, Proc Natl Acad Sci USA 1993 90 770 774 10.1073/pnas.90.2.770 8421714 (Pubitemid 23028947)